| Net income | -32.6M |
| Depreciation and amortization | 46.1M |
| Provision for doubtful accounts | |
| Gain on disposition of assets | |
| Stock-based compensation | 101.1M |
| Excess tax benefit-stock awards | |
| Effect of fair value option on credit facility issuance and refinancing costs | |
| Accounts receivable | -22.1M |
| Inventories | 80.2M |
| Other current assets | -20.3M |
| Other assets | 2.2M |
| Deferred income taxes | |
| Accounts payable and accrued liabilities | |
| Income taxes payable | |
| Other long term liabilities | 89.7M |
| Net cash provided by operating activities | 274.6M |
| Proceeds from redemption of available for sale auction rate securities | |
| Purchases of property and equipment | -48.8M |
| Changes in other assets | |
| Proceeds from the sales of assets | |
| Payments for acquisitions, net of cash acquired | -1.69B |
| Net cash used in investing activities | -1.41B |
| Repayments of auction rate securities credit facility | |
| Repayments of credit facility | -1.13B |
| Borrowings on credit facility | |
| Credit facility issuance and refinancing costs | -53.8M |
| Repayment of note payable | |
| Excess tax benefit-stock awards | |
| Stock settled tax withholdings | 42.4M |
| Proceeds from exercise of stock options | 5.1M |
| Net cash provided by (used in) financing activities | 1.07B |
| Net increase (decrease) in cash and cash equivalents | -66.9M |
| Cash and cash equivalents at beginning of period | 256.4M |
| Cash and cash equivalents at end of period | 189.5M |